FDA Could Approve First CRISPR Treatment in US Before Year End, Marking New Territory for Gene Editing Tech
![](https://www.mcalindenresearchpartners.com/wp-content/uploads/2023/06/anirudh-tiTzBRnr7PY-unsplash-1024x585.jpg)
CRISPR gene editing therapies took a big step toward commercialization in the United States last week, as the FDA laid…
McAlinden Research PartnersJune 13, 2023